Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 15/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8707904 | 0.83 | BRD4 (0.39) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8551195 | 0.81 | CYP3A4 (0.41) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8545648 | 0.81 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8547631 | 0.79 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8550976 | 0.79 | CYP3A4 (0.40) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8306273 | 0.78 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8702103 | 0.78 | SIRT2 (0.43) | CYP3A4CYP2C9CYP2C19BRD4 | |
| SCHEMBL8703807 | 0.77 | CYP3A4 (0.41) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8701594 | 0.77 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8701190 | 0.77 | CYP3A4 (0.42) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5837704-A | PREVENTION OR TREATMENT OF AIDS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1998-11-17 | — | — | US | disclosed |